Endocrine Essentials: Endocrine Update for General Medicine

The Endocrine Essentials Series captures and compiles new and current information on the diagnosis, treatment, and management of endocrine disorders. This series covers a wide range of topics, providing invaluable reading for physicians at all levels.

Target Audience

This continuing medical education activity should be of substantial interest to endocrinologists, internists and family practitioners who care for patients with endocrine disorders.

Learning Objectives

The educational content of this volume is provided in a case-based format, with questions designed to assess competence in the diagnoses and management of endocrine disorders. While the topics vary, covering multiple aspects of endocrinology, the learning objectives apply to problem solving for a variety of endocrine disorders.

Upon completion of this enduring activity, participants shouldbe able to:

  • List common causes or risk factors for diabetes, endocrine, and metabolic disorders and choose appropriate strategies of therapy
  • Identify and differentiate endocrine cases that can be treated in a primary care setting and those that are in need of referral to an endocrinologist for treatment
  • Recognize factors important in the evaluation and diagnosis of common endocrine disorders and formulate a treatment plan in a primary care setting

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
General Endocrinology
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 12.00 AMA PRA Category 1 Credits
  • 12.00 CME Certificate of Participation
Course opens: 
Course expires: 

Disclosure Information

Authors, editors, reviewers, Endocrine Society staff and others involved in planning this CME activity are required to disclose to learners any relevant financial relationship(s) that have occurred within the last 12 months with any commercial interest(s) whose products or services are discussed in the CME content. Such relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent faculty with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments. It remains for learners to determine whether financial interests or relationships may influence the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The editor and following authors reported no relevant financial relationships:

Robert A. Adler, MD, Bradley Anawalt, MD, Richard Auchus, MD, PhD, Daniel D. Bikle, MD, PhD, Glenn D. Braunstein, MD, Gregory Brent, MD, Luiza Caramori, MD, MS, PhD, Anthony DeSantis, MD, Richard Eastell, MD, FRCP, FCRPath, FMedSci, Kenneth Feingold, MD, James Findling, MD, Hossein Gharib, MD, MACP, MACE, SiriAtma Greeley, MD, PhD, Francis Hayes, MB, FRCPI, Mara J. Horwitz, MD, Mary Korytkowski, MD, Michael A. Levine, MD, Alvin M. Matsumoto, MD, Anthony L. McCall, MD, PhD, FACP, Alastair R. McLellan, MD, FRCP, Graham T. McMahon, MD, MMSc, Rochelle Naylor, MD, Catherine B. Niewoehner, MD, Louis H. Philipson, MD, PhD, Clifford Rosen, MD, Lisa Tannock, MD, Bu B. Yeap, MBBS, FRACP, Thomas Weber, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

The following authors/faculty reported relevant financial relationships:

Graeme I. Bell, PhD , Employee, KAI Pharmaceuticals

Kenneth Burman, MD , Consultant, Up To Date; Investigator, Exelixis, Inc., Amgen, Pfizer, Inc.

Alan Chait, MD , Disclosures Incomplete

Samuel Dagogo-Jack, MD , Consultant, Lilly USA, LLC, GlaxoSmithKline, Merck & Co., Roche Pharmaceuticals; Speaker, Eli Lilly & Company, GlaxoSmithKline; Principal Investigator, Astra Zeneca, Bristol-Myers Squibb

Catherine M. Gordon, MD, MSc , Associate Director, Harvard/MIT and Pfizer/Merck Sponsored Fellowship Training Program, Pfizer, Inc.

Irl B. Hirsch, MD , Consultant, Johnson & Johnson, Roche Diagnostics

Douglas S. Ross, MD , Researcher, Celera

Policy on Unlabeled/Off-Label Use

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners.

Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

Privacy and Confidentiality Statement

The Endocrine Society will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

Available Credit

  • 12.00 AMA PRA Category 1 Credits
  • 12.00 CME Certificate of Participation